Patents Assigned to Schering Aktiengesellschaft and Board of Regents
  • Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
    Patent number: 5906987
    Abstract: The symptoms of climacterium in male mammals, e.g., hypertension, cardiovascular disease and osteoporosis, are ameliorated by the administration to an afflicted individual one or both of a nitric oxide substrate and/or nitric acid donor, in combination with an androgen, an aromatase inhibitor or both, wherein the circulating levels of testosterone in the afflicted individual are increased.
    Type: Grant
    Filed: March 10, 1997
    Date of Patent: May 25, 1999
    Assignees: Schering Aktiengesellschaft and Board of Regents, The University of Texas System
    Inventors: Kristof Chwalisz, Robert E. Garfield